Australian scientists from the Centenary Institute, in partnership with the University of Sydney, have unveiled PROTEUS (PROTein Evolution Using Selection) – a breakthrough platform that brings protein evolution into mammalian cells. This innovative method sets a new stage for developing medical treatments that are tailored for the human body.
Unlike traditional techniques that rely on bacteria or yeast, PROTEUS uses virus-like particles to induce mutations and select proteins with enhanced functions in a more relevant cell environment. This approach not only mirrors the complexity of human cells but also paves the way for advancements in gene therapy, disease research, and next-generation treatments.
Early demonstrations have already shown promising results, with researchers improving a gene-regulating protein and evolving a nano-body capable of detecting DNA damage – a key element in cancer research. For tech enthusiasts and healthcare innovators alike, this marks an exciting step toward personalized therapies that truly work where they are needed.
From the vibrant tech hubs of South and Southeast Asia to research labs around the globe, breakthroughs like PROTEUS echo a future where medical treatments are as dynamic and adaptable as our fast-paced lives. Stay tuned as such innovation drives forward the next era of biotech! 🚀🔥
Reference(s):
New platform transforms protein evolution for next-gen therapies
cgtn.com
